Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 163.59 USD -0.18% Market Closed
Market Cap: 18.3B USD
Have any thoughts about
Quest Diagnostics Inc?
Write Note

Quest Diagnostics Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Quest Diagnostics Inc
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Quest Diagnostics Inc
NYSE:DGX
Retained Earnings
$9.2B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
5%
DaVita Inc
NYSE:DVA
Retained Earnings
$1.3B
CAGR 3-Years
-8%
CAGR 5-Years
-18%
CAGR 10-Years
-11%
Chemed Corp
NYSE:CHE
Retained Earnings
$2.6B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
13%
CVS Health Corp
NYSE:CVS
Retained Earnings
$62B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
7%
Cigna Corp
NYSE:CI
Retained Earnings
$42.5B
CAGR 3-Years
10%
CAGR 5-Years
17%
CAGR 10-Years
11%
Laboratory Corporation of America Holdings
NYSE:LH
Retained Earnings
$8.3B
CAGR 3-Years
-8%
CAGR 5-Years
2%
CAGR 10-Years
8%
No Stocks Found

Quest Diagnostics Inc
Glance View

Market Cap
18.3B USD
Industry
Health Care

Quest Diagnostics Inc. is a leading provider of diagnostic testing and information services, playing a crucial role in the healthcare ecosystem. With a legacy dating back to the 1960s, Quest has established itself as a trusted partner for healthcare providers by offering a wide range of testing services, including routine blood tests, genetic testing, and specialized diagnostics for chronic diseases. The company's innovative approach to testing, bolstered by its extensive network of laboratories and state-of-the-art technology, ensures accurate and timely results, empowering patients and physicians alike to make informed healthcare decisions. As an industry leader, Quest not only aids in clinical decision-making but also plays a pivotal role in the ongoing shift toward value-based care, which emphasizes quality over quantity in patient treatment. For investors, Quest Diagnostics represents an attractive opportunity due to its strong financial performance and growth potential. The company benefits from a robust demand for diagnostic testing services, especially in the wake of the COVID-19 pandemic, which has heightened awareness of the importance of timely medical diagnostics. Quest's investment in cutting-edge technology and telehealth solutions positions it well to adapt to the evolving healthcare landscape. With a track record of consistent revenue growth and a commitment to returning value to shareholders through dividends and share buybacks, Quest Diagnostics stands out as a solid investment in the healthcare sector, blending stability with innovation in a critical industry.

DGX Intrinsic Value
147.89 USD
Overvaluation 10%
Intrinsic Value
Price

See Also

What is Quest Diagnostics Inc's Retained Earnings?
Retained Earnings
9.2B USD

Based on the financial report for Sep 30, 2024, Quest Diagnostics Inc's Retained Earnings amounts to 9.2B USD.

What is Quest Diagnostics Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
5%

Over the last year, the Retained Earnings growth was 6%. The average annual Retained Earnings growth rates for Quest Diagnostics Inc have been 8% over the past three years , 3% over the past five years , and 5% over the past ten years .

Back to Top